Viewing Study NCT07052903


Ignite Creation Date: 2025-12-24 @ 7:48 PM
Ignite Modification Date: 2026-01-03 @ 2:51 AM
Study NCT ID: NCT07052903
Status: RECRUITING
Last Update Posted: 2025-12-19
First Post: 2025-06-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Sponsor: Alnylam Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module